Bio-K Plus International Inc. clinical trials
Acquired by Kerry Group plc, Oct 2020 · source ↗
The registry lists 8 studies whose lead sponsor is Bio-K Plus International Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 22, 2022.
Before and after it joined Kerry Group plc
- First submitted before Bio-K Plus International Inc. became part of Kerry Group plc
- 8
- First submitted after Bio-K Plus International Inc. became part of Kerry Group plc
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Bio-K Plus International Inc.8 studies
Something wrong with this grouping? Tell us on the Kerry Group plc page.
Studies
Recruiting first, then most recently updated. Showing 8 of 8. All Kerry Group plc studies →
- Evaluation of the Efficacy of Bio-K+ Cl-1285® In the Nasal Decolonization of Methicillin Resistant Staphylococcus Aureus (MRSA) Carrier PatientsWithdrawnNCT00941356Phase 2
Sponsor listed in the registry: Bio-K Plus International Inc. · First submitted before Bio-K Plus International Inc. became part of Kerry Group plc
- Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated DiarrheaTerminatedNCT01972932Phase 4
Sponsor listed in the registry: Bio-K Plus International Inc. · First submitted before Bio-K Plus International Inc. became part of Kerry Group plc
- A Study to Evaluate the Effect of BioK+ 50B® on Glycemic Control in a Type 2 Diabetes PopulationStatus unknownNCT03239366Phase 2
Sponsor listed in the registry: Bio-K Plus International Inc. · First submitted before Bio-K Plus International Inc. became part of Kerry Group plc
- Effect of BIO-K+ on Symptoms of Irritable Bowel SyndromeCompletedNCT01545037Phase 2
Sponsor listed in the registry: Bio-K Plus International Inc. · First submitted before Bio-K Plus International Inc. became part of Kerry Group plc
- BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile InfectionSuspendedNCT01202630Phase 3
Sponsor listed in the registry: Bio-K Plus International Inc. · First submitted before Bio-K Plus International Inc. became part of Kerry Group plc
- Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult PatientsCompletedNCT00328263Phase 3
Sponsor listed in the registry: Bio-K Plus International Inc. · First submitted before Bio-K Plus International Inc. became part of Kerry Group plc
- Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial InfectionCompletedNCT00958308Phase 3
Sponsor listed in the registry: Bio-K Plus International Inc. · First submitted before Bio-K Plus International Inc. became part of Kerry Group plc
- Efficacy of BIO-K+ CL1285® Prophylaxis in the Prevention of Traveler's Diarrhea in AdultsCompletedNCT00737412Phase 3
Sponsor listed in the registry: Bio-K Plus International Inc. · First submitted before Bio-K Plus International Inc. became part of Kerry Group plc